Colorcon increases Suglets manufacturing capacity by 50%
Investments being made ahead of anticipated demand.
Film coating systems supplier Colorcon has increased manufacturing capacity for its Suglets, sugar spheres range.
"As growth continues for multiparticulate dosage forms, especially for geriatric and pediatric populations, there is an ongoing need in the industry for a consistent supplier who provides a high-quality sphere for multiparticulate products, with a robust business continuity plan. New investments, which increase our annual capacity by 50%, are being made ahead of anticipated demand to manage product availability efficiently for our customers,” says Deborah Taylor, Global Market Communications Manager.
"At Colorcon, we have continued to improve and expand our sphere operations to offer the best quality product from our two Suglets manufacturing locations, Stoughton, Wisconsin, US, and Bazainville, France. As the only manufacturer dedicated to the production of spheres for pharmaceutical use, we have the ability to produce equivalent products from both sites, providing much-desired business continuity.”
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.